Conceptual note interprets 3TR as a model of cross-disease immune states, suggesting a new classification for immune diseases.
This conceptual note interprets the 3TR consortium — Taxonomy, Treatment, Targets and Remission — as an example of external convergence with dynamic medicine. 3TR studies autoimmune, inflammatory and allergic diseases together in order to identify shared molecular mechanisms of treatment response, non-response, relapse and remission across traditional diagnostic boundaries. The note does not claim that 3TR validates the Universal Resonance Model (URM). Rather, it argues that 3TR illustrates a broader movement in contemporary immunology: from static diagnostic silos toward cross-disease immune states, longitudinal disease trajectories, molecular signatures, patient heterogeneity and treatment-response patterns. The central argument is that future classification of immune-mediated disease may require two complementary layers: the traditional diagnostic layer, which remains clinically necessary, and a dynamic state layer based on trajectories, shared mechanisms, molecular signatures and treatment-response patterns. This note is part of the URM / Dynamic Medicine Series and should be read as an external convergence note, not as an empirical validation study.
No takes yet. Share an insight, caveat, or question.
Anita Domargård (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: